Ann‐Shing Lee

767 total citations
7 papers, 118 citations indexed

About

Ann‐Shing Lee is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Ann‐Shing Lee has authored 7 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Ann‐Shing Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Ann‐Shing Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Ann‐Shing Lee collaborates with scholars based in China and Hong Kong. Ann‐Shing Lee's co-authors include Stephen L. Chan, Victor Lee, Philip Chong‐hei Kwok, To‐Wai Leung, Thomas Yau, Simon C.H. Yu, Mai‐Yee Luk, Stewart Y. Tung, Osamu Saiki and Moon‐Tong Cheung and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Surgical Oncology.

In The Last Decade

Ann‐Shing Lee

7 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann‐Shing Lee China	5	89	49	38	24	24	7	118
Elsayed Mostafa Ali Egypt	8	31 0.3×	20 0.4×	34 0.9×	22 0.9×	36 1.5×	18	123
Marc-Antoine Allard France	3	115 1.3×	74 1.5×	21 0.6×	22 0.9×	105 4.4×	5	150
Laurent Vervueren France	5	39 0.4×	29 0.6×	27 0.7×	49 2.0×	35 1.5×	8	156
Răzvan Grigorie Romania	7	115 1.3×	83 1.7×	60 1.6×	24 1.0×	54 2.3×	18	170
Dongbo Xu China	5	115 1.3×	56 1.1×	41 1.1×	43 1.8×	36 1.5×	22	176
Sabrina Hartenbach Austria	4	18 0.2×	26 0.5×	22 0.6×	44 1.8×	24 1.0×	10	119
David W.G. ten Cate Netherlands	7	50 0.6×	67 1.4×	32 0.8×	42 1.8×	66 2.8×	16	157
Emiel J.C. Sturm Belgium	5	52 0.6×	26 0.5×	22 0.6×	23 1.0×	20 0.8×	5	94
Reona Morio Japan	8	129 1.4×	39 0.8×	81 2.1×	12 0.5×	18 0.8×	11	149

Countries citing papers authored by Ann‐Shing Lee

Since Specialization

Citations

This map shows the geographic impact of Ann‐Shing Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Shing Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Shing Lee more than expected).

Fields of papers citing papers by Ann‐Shing Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Shing Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Shing Lee. The network helps show where Ann‐Shing Lee may publish in the future.

Co-authorship network of co-authors of Ann‐Shing Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Shing Lee. A scholar is included among the top collaborators of Ann‐Shing Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Shing Lee. Ann‐Shing Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cheung, Tan To, Simon C.H. Yu, Stephen L. Chan, et al.. (2022). The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021. HepatoBiliary Surgery and Nutrition. 12(3). 366–385. 7 indexed citations

2.

Wong, Tiffany, Chi‐Leung Chiang, Ann‐Shing Lee, et al.. (2019). Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surgical Oncology. 28. 228–235. 24 indexed citations

3.

Yau, Thomas Cheung, Vikki Tang, Roland Leung, et al.. (2019). Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 37(4_suppl). 365–365. 3 indexed citations

4.

Tang, Vikki, Roland Leung, Ann‐Shing Lee, et al.. (2019). Randomized phase II trial of sorafenib, capecitabine, and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 37(15_suppl). e15630–e15630. 1 indexed citations

5.

Kwok, Philip Chong‐hei, Stephen L. Chan, Ann‐Shing Lee, et al.. (2018). Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. Liver Cancer. 7(1). 40–54. 26 indexed citations

6.

Poon, Ronnie Tung‐Ping, Philip Chong‐hei Kwok, Ann‐Shing Lee, et al.. (2015). Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma. Liver Cancer. 4(1). 51–69. 38 indexed citations

7.

Leung, To‐Wai, Stewart Y. Tung, Victy Y.W. Wong, et al.. (2005). Nasopharyngeal intracavitary brachytherapy. Cancer. 104(8). 1648–1655. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact